Abbott Laboratories Share Price London S.E.
Stocks
ABT
US0028241000
Medical Equipment, Supplies & Distribution
|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 106.90 USD | +2.86% |
|
+3.60% | -15.03% |
| 01/08 | Amgen discloses data breach involving patient health information | RE |
| 31/07 | Dexcom raises annual revenue forecast on strong demand for glucose monitors | RE |
| Market Cap | 18TCr 16TCr 15TCr 14TCr 26TCr 17,46000Cr 26TCr 1,74400Cr 68TCr 8,69200Cr 69TCr 67TCr 29,14700Cr | P/E 2026 * |
30.3x | P/E 2027 * | 23.4x |
|---|---|---|---|---|---|
| Enterprise Value | 21TCr 18TCr 17TCr 15TCr 29TCr 19,76700Cr 29TCr 1,97500Cr 78TCr 9,84100Cr 78TCr 76TCr 32,99800Cr | EV / Sales 2026 * |
4.12x | EV / Sales 2027 * | 3.74x |
| Free-Float |
86.16% | Yield 2026 * |
2.44% | Yield 2027 * | 2.59% |
Last Transcript: Abbott Laboratories
| 1 day | +2.86% | ||
| 1 week | +3.60% | ||
| Current month | +1.10% | ||
| 1 month | +12.56% | ||
| 3 months | +19.08% | ||
| 6 months | -1.93% | ||
| Current year | -15.03% |
| 1 week | 102 |  | 110.02 |
| 1 month | 87.66 | | 110.02 |
| Current year | 82.05 | | 129.37 |
| 1 year | 82.05 | | 137.44 |
| 3 years | 82.05 | | 141.41 |
| 5 years | 82.05 | | 142.15 |
| 10 years | 38.23 | | 142.15 |
| Manager | Title | Age | Since |
|---|---|---|---|
Robert Ford
CEO | Chief Executive Officer | 52 | 31/03/2020 |
Philip Boudreau
DFI | Director of Finance/CFO | 53 | 01/09/2023 |
Sabina Ewing
CIO | Chief Investment Officer | 51 | - |
| Director | Title | Age | Since |
|---|---|---|---|
Sally Blount
BRD | Director/Board Member | 64 | 09/12/2011 |
Nancy McKinstry
BRD | Director/Board Member | 67 | 09/12/2011 |
Daniel Starks
BRD | Director/Board Member | 71 | 16/02/2017 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +2.86% | +3.60% | - | - | 18TCr | |
| -0.37% | +2.62% | -4.42% | -0.08% | 11TCr | |
| -0.29% | +0.47% | +7.97% | +62.64% | 6.06TCr | |
| -0.04% | -0.22% | +36.56% | +51.77% | 5.18TCr | |
| +0.10% | +5.92% | -6.10% | -40.04% | 4.56TCr | |
| +0.41% | +1.37% | - | - | 3.32TCr | |
| +11.95% | +16.65% | +5.26% | -32.60% | 3.15TCr | |
| +0.40% | +3.89% | +42.51% | -7.99% | 2.4TCr | |
| -1.22% | +6.69% | +0.67% | +0.26% | 2.23TCr | |
| -0.99% | +2.18% | -9.69% | +3.89% | 2.15TCr | |
| Average | +1.27% | +5.39% | +9.10% | +4.73% | 4.44TCr | |
| Weighted average by Cap. | +1.40% | +4.12% | +7.11% | +9.58% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 5.03TCr 4.37TCr 4.07TCr 3.74TCr 7.06TCr 4,80200Cr 7.17TCr 48TCr 19TCr 2,39100Cr 19TCr 18TCr 8,01600Cr | 5.46TCr 4.75TCr 4.42TCr 4.06TCr 7.67TCr 5,21700Cr 7.79TCr 52TCr 20TCr 2,59700Cr 21TCr 20TCr 8,70900Cr |
| Net income | 625.49Cr 543.74Cr 506.1Cr 464.66Cr 877.48Cr 60TCr 891.07Cr 5.97TCr 2.34TCr 30TCr 2.35TCr 2.3TCr 1LCr | 792.32Cr 688.77Cr 641.09Cr 588.6Cr 1.11TCr 76TCr 1.13TCr 7.56TCr 2.97TCr 38TCr 2.98TCr 2.91TCr 1,26300Cr |
| Net Debt | 2.42TCr 2.1TCr 1.96TCr 1.8TCr 3.39TCr 2,30700Cr 3.44TCr 23TCr 9.05TCr 1,14800Cr 9.08TCr 8.88TCr 3,85100Cr | 2.14TCr 1.86TCr 1.73TCr 1.59TCr 3TCr 2,04400Cr 3.05TCr 20TCr 8.02TCr 1,01800Cr 8.04TCr 7.87TCr 3,41300Cr |
| Date | Price | Change | Volume |
|---|---|---|---|
| 31/26/31 | $105.74 | -0.07% | 3,564 |
| 30/26/30 | $105.81 | -2.43% | 7,381 |
| 29/26/29 | $108.45 | +0.92% | 2,716 |
| 28/26/28 | $107.46 | +1.89% | 34,084 |
| 27/26/27 | $105.47 | +2.21% | 4,730 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- ABT Stock
- ABT Stock
Select your edition
All financial news and data tailored to specific country editions
